- Gallup: Take Care Clinics top in customer service
- The Little Clinic adds new insurance provider to accepted plans
- Rite Aid takes a bite out of obesity; relaunches weight-loss program for New Year
- Bartell to cease filling Medicaid prescriptions at 15 locations
- More progress needed in health information technology
WILMINGTON, Del. With September marked as National Cholesterol Education Month, drug maker AstraZeneca is using the occasion to push lifestyles that promote low cholesterol, the Anglo-Swedish company said.
AstraZeneca, which markets the cholesterol-lowering drug Crestor (rosuvastatin calcium), is pushing such habits as a healthy diet and exercise as ways to keep cholesterol down. According to the American Heart Association, 102 million Americans ages 20 years and older have borderline-high or high cholesterol.
“The patient-doctor partnership is one of the most critical relationships you can have, and National Cholesterol Education Month can be a reminder to see your doctor, talk about your cholesterol numbers and target goal, and understand how to assess your cardiovascular risk,” physician and founder of the Texas-based Legacy Heart Center Waenard Miller said in a statement on behalf of AstraZeneca.